Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era

被引:17
|
作者
Li, Qian [1 ]
Yu, Lushi [1 ]
Yang, Pengcheng [1 ]
Hu, Qinyong [1 ]
机构
[1] Wuhan Univ, Canc Ctr, Renmin Hosp, 238 Jie Fang Rd, Wuhan 430060, Hubei, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
nasopharyngeal carcinoma; neutrophil-to-lymphocyte ratio; platelet-to-lymphocyte ratio; systemic immune inflammation index; systemic inflammatory response index; prognosis; RESPONSE INDEX SIRI; HEMATOLOGICAL BIOMARKERS; CANCER; SURVIVAL; OUTCOMES; PATTERNS; NOMOGRAM; RATIO;
D O I
10.2147/CMAR.S311094
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Inflammatory markers have been widely used in various cancers, but rarely in nasopharyngeal carcinoma (NPC). Here, we evaluated the prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR), platelet-lymphocyte-ratio (PLR), systemic immune index (SII), and systemic inflammation response index (SIRI) on NPC in the intensitymodulated radiotherapy (IMRT) era. Methods: We retrospectively analyzed data from NPC patients from the Renmin Hospital of Wuhan University, between January 2012 and July 2020. We used Chi-square test or Fisher's exact test to compare the baseline characteristics, then applied Kaplan-Meier (K-M) survival analysis to compare the overall survival (OS) and progression-free survival (PFS) rates. Multivariate Cox proportional risk models were applied to identify independent prognostic factors. Results: We enrolled a total of 342 NPC patients and found optimal cut-off values of 2.65, 184.91, 804.08, and 1.34 for NLR, PLR, SII, and SIRI, respectively. K-M survival analysis revealed that high NLR, PLR, SII, and SIRI were significantly associated with worse OS and PFS relative to those in the low groups. Results from univariate Cox analysis showed that clinical, T, and M stages, as well as NLR, PLR, SII, and SIRI were associated with OS, whereas age, alongside the aforementioned parameters, was associated with PFS. Moreover, multivariate Cox analysis showed that age >49 years (HR=2.48, 95% CI=1.21-5.05, P=0.013) and M1 stage (HR=3.84, 95% CI=1.52-9.73, P=0.013) were independent prognostic factors for OS, whereas SIRI >1.34 (HR=1.91, 95% CI=1.05-3.47, P=0.034) and M1 stage (HR=2.91, 95% CI=1.44-5.86, P=0.003) were independent prognostic factors for PFS. Conclusion: Overall, our findings indicated that high NLR, PLR, SII, and SIRI were significantly associated with poor OS and PFS in NPC patients. High SIRI may be an independent risk factor for PFS of NPC patients in the IMRT era. Keywords: nasopharyngeal carcinoma, neutrophil-to-lymphocyte ratio, platelet-tolymphocyte ratio, systemic immune inflammation index, systemic inflammatory response
引用
收藏
页码:6799 / 6810
页数:12
相关论文
共 50 条
  • [31] Prognostic value of Diabetes in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy
    Peng, Hao
    Chen, Lei
    Zhang, Yuan
    Li, Wen-Fei
    Mao, Yan-Ping
    Zhang, Fan
    Guo, Rui
    Liu, Li-Zhi
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [32] Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy
    Chang, Hui
    Wei, Jia-wang
    Chen, Kai
    Zhang, Shu
    Han, Fei
    Lu, Li-xia
    Xiao, Wei-wei
    Gao, Yuan-hong
    [J]. JOURNAL OF CANCER, 2018, 9 (04): : 702 - 710
  • [33] Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
    Yu-Xiang He
    Ying Wang
    Peng-Fei Cao
    Lin Shen
    Ya-Jie Zhao
    Zi-Jian Zhang
    Deng-Ming Chen
    Tu-Bao Yang
    Xin-Qiong Huang
    Zhou Qin
    You-Yi Dai
    Liang-Fang Shen
    [J]. 癌症, 2016, 35 (12) : 725 - 734
  • [34] Prognostic Value and Staging Classification of Retropharyngeal Lymph Node Metastasis in Nasopharyngeal Carcinoma Patients Treated with Intensity-modulated Radiotherapy
    Tang, Ling-Long
    Guo, Rui
    Zhou, Guanqun
    Sun, Ying
    Liu, Li-Zhi
    Lin, Ai-Hua
    Mai, Haiqiang
    Shao, Jianyong
    Li, Li
    Ma, Jun
    [J]. PLOS ONE, 2014, 9 (10):
  • [35] Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
    He, Yu-Xiang
    Wang, Ying
    Cao, Peng-Fei
    Shen, Lin
    Zhao, Ya-Jie
    Zhang, Zi-Jian
    Chen, Deng-Ming
    Yang, Tu-Bao
    Huang, Xin-Qiong
    Qin, Zhou
    Dai, You-Yi
    Shen, Liang-Fang
    [J]. CHINESE JOURNAL OF CANCER, 2016, 35 : 96
  • [36] Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
    Feng, Yanru
    Cao, Caineng
    Hu, Qiaoying
    Chen, Xiaozhong
    [J]. CANCER RESEARCH AND TREATMENT, 2019, 51 (03): : 1222 - 1230
  • [37] Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy
    Wang, Weidong
    Feng, Mei
    Fan, Zixuan
    Li, Jie
    Lang, Jinyi
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [38] Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
    Y-M Tian
    Y-H Tian
    L Zeng
    S Liu
    Y Guan
    T-X Lu
    F Han
    [J]. British Journal of Cancer, 2014, 110 : 297 - 303
  • [39] Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy
    Zeng, Lei
    Guo, Pi
    Li, Jin-Gao
    Han, Fei
    Li, Qiang
    Lu, Yong
    Deng, Xiao-Wu
    Zhang, Qing-Ying
    Lu, Tai-Xiang
    [J]. ONCOTARGET, 2015, 6 (36) : 39373 - 39383
  • [40] Prognostic analysis of 152 patients with distant metastasis after intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Yang, Hua
    Liu, Changhao
    Luo, Shanquan
    Ma, Rui
    Zhou, Yan
    Yin, Yutian
    Zhao, Lina
    Shi, Mei
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (06) : 6824 - 6832